Pollogen Launches New Facial Platform

Pollogen, a leader in the medical aesthetic market, introduced geneO+, an aesthetic device specifically developed for skincare professionals. Designed for clients to detect results after only one treatment, geneO+ is a smart-touch system that integrates OxyGeneo technology, which can deliver three treatments simultaneously—exfoliation of the outer layer skin, infusion of revitalizing nutrients, and oxygenation of the skin. The device can also operate independently or can be combined with other aesthetic regimens. "We are very excited about launching our newest innovation geneO+,” says CEO Amichai Bar-Nir. “OxyGeneo technology has been well received by skincare practitioners around the world who are experiencing patient satisfaction well beyond what they expected. We feel that the geneO+ will offer real business value for skincare professionals and phenomenal results for their patients."

Suggested Articles

Crown is now poised to become a global leader in dermatology health and wellness.

Holly Cutler shares her expert thoughts on what to expect from medical spas in 2020.

Allergan Aesthetics will operate as a new business with its own research and development function under the AbbVie umbrella.